<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE article  PUBLIC "-//NLM//DTD Journal Publishing DTD v3.0 20080202//EN" "http://dtd.nlm.nih.gov/publishing/3.0/journalpublishing3.dtd"><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" dtd-version="3.0" xml:lang="en" article-type="research article"><front><journal-meta><journal-id journal-id-type="publisher-id">AJPS</journal-id><journal-title-group><journal-title>American Journal of Plant Sciences</journal-title></journal-title-group><issn pub-type="epub">2158-2742</issn><publisher><publisher-name>Scientific Research Publishing</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.4236/ajps.2014.59151</article-id><article-id pub-id-type="publisher-id">AJPS-45238</article-id><article-categories><subj-group subj-group-type="heading"><subject>Articles</subject></subj-group><subj-group subj-group-type="Discipline-v2"><subject>Biomedical&amp;Life Sciences</subject></subj-group></article-categories><title-group><article-title>
 
 
  Cembrane-Type Diterpenoids and a Phenolic Compound from the Leaves of a Thai Medicinal Plant, &lt;i&gt;Croton sublyratus&lt;/i&gt; Kurz
 
</article-title></title-group><contrib-group><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>asue</surname><given-names>Oka</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Susumu</surname><given-names>Kawakami</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Sachiko</surname><given-names>Sugimoto</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Katsuyoshi</surname><given-names>Matsunami</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Hideaki</surname><given-names>Otsuka</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref><xref ref-type="corresp" rid="cor1"><sup>*</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Duanporn</surname><given-names>Lhieochaiphant</given-names></name><xref ref-type="aff" rid="aff2"><sup>2</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Sorasak</surname><given-names>Lhieochaiphant</given-names></name><xref ref-type="aff" rid="aff3"><sup>3</sup></xref></contrib></contrib-group><aff id="aff1"><addr-line>Department of Pharmacognosy, Graduate School of Bio-medical and Health Sciences, Hiroshima 
University, Hiroshima, Japan</addr-line></aff><aff id="aff2"><addr-line>Department of Pharmaceutical Sciences, Faculty of Pharmacy, Chiang Mai University, Chiang Mai,
Thailand</addr-line></aff><aff id="aff3"><addr-line>Faculty of Pharmacy, Payap University, Chiang Mai, Thailand</addr-line></aff><author-notes><corresp id="cor1">* E-mail:<email>hotsuka@hiroshima-ac.jp, otsuka-h@yasuda-u.ac.jp(HO)</email>;</corresp></author-notes><pub-date pub-type="epub"><day>01</day><month>04</month><year>2014</year></pub-date><volume>05</volume><issue>09</issue><fpage>1370</fpage><lpage>1377</lpage><history><date date-type="received"><day>19</day>	<month>February</month>	<year>2014</year></date><date date-type="rev-recd"><day>28</day>	<month>March</month>	<year>2014</year>	</date><date date-type="accepted"><day>14</day>	<month>April</month>	<year>2014</year></date></history><permissions><copyright-statement>&#169; Copyright  2014 by authors and Scientific Research Publishing Inc. </copyright-statement><copyright-year>2014</copyright-year><license><license-p>This work is licensed under the Creative Commons Attribution International License (CC BY). http://creativecommons.org/licenses/by/4.0/</license-p></license></permissions><abstract><p>
 
 
   From the leaves of a Thai medicinal plant, Croton sublyratus, collected in Thailand, two new cembrane-type diterpenoids, named sublylactones A and B, and a phenolic compound were isolated from the EtOAc-soluble fraction of a MeOH extract. Their structures were elucidated on the basis of spectroscopic evidence. 
 
</p></abstract><kwd-group><kwd>Croton Sublyratus; Euphorbiaceae; Diterpene; Cembrane</kwd></kwd-group></article-meta></front><body><sec id="s1"><title>1. Introduction</title><p>Croton sublyratus, belonging to the Euphorbiaceae family, is called “Plau-Noi” in Thai. An acyclic diterpene alcohol, plaunotol, was isolated from this plant [<xref ref-type="bibr" rid="scirp.45238-ref1">1</xref>] , which is already on the market as an anti-ulcerative agent called Kelnac [<xref ref-type="bibr" rid="scirp.45238-ref2">2</xref>] . Diterpenelactones, plaunols A and B [<xref ref-type="bibr" rid="scirp.45238-ref3">3</xref>] [<xref ref-type="bibr" rid="scirp.45238-ref4">4</xref>] , and ent-labdane and ent-kaurane [<xref ref-type="bibr" rid="scirp.45238-ref5">5</xref>] have also been isolated from C. sublyratus. From this plant, isolation of a furanoid diterpene was also reported [<xref ref-type="bibr" rid="scirp.45238-ref6">6</xref>] [<xref ref-type="bibr" rid="scirp.45238-ref7">7</xref>] . Our reinvestigation of constituents of C. sublyratus resulted in the isolation of two cembrane-type diterpenoids, named sublylactones A (1) and B (2), and a phenolic compound (3) together with a known cembrane-type diterpenoid, laevigatlactone E (4), which has also been isolated from Croton laevigatus [<xref ref-type="bibr" rid="scirp.45238-ref8">8</xref>].</p></sec><sec id="s2"><title>2. Results and discussion</title><p>From the EtOAc-soluble fraction of a MeOH extract, two new cembrane-type diterpenes (1 and 2) and a phenolic compound (3) (<xref ref-type="fig" rid="fig1">Figure 1</xref>) were isolated by a combination of various types of chromatography. Their structures were elucidated from spectroscopic evidence.</p><p>Sublylactone A (1), [α]<sub>D</sub><sup>23</sup> +3.90, was isolated as an amorphous powder and its elemental composition was determined to be C<sub>20</sub>H<sub>30</sub>O<sub>4</sub> by the observation of a quasi-molecular ion (C<sub>20</sub>H<sub>30</sub>O<sub>4</sub>Na) on high-resolution (HR)- electrospray ionization (ESI)-mass spectroscopy (MS). The IR spectrum exhibited absorption bands for hydroxyl groups (3423 cm<sup>‒1</sup>), C-H (2968, 2929 and 2881 cm<sup>‒1</sup>), a lactone (1697 cm<sup>‒1</sup>), and double bonds (1631 cm<sup>‒1</sup>), and the UV spectrum indicated the presence of a conjugated system (234 nm). In the <sup>1</sup>H-NMR spectrum, signals assignable to two singlet methyls, two doublet methyls and five olefinic protons were observed (<xref ref-type="table" rid="table1">Table 1</xref>). The <sup>13</sup>C-NMR spectrum showed twenty signals that were assignable to four methyls, five methylenes, one methine, three oxygenated tertiary carbons, three double bonds and a carbonyl carbon (<xref ref-type="table" rid="table2">Table 2</xref>). Of the three double bonds, two were disubstituted ones and their geometry was determined to be E from the coupling constants of olefinic protons on them. <sup>1</sup>H-<sup>1</sup>H correlation spectroscopy (COSY) established five partial structures, A: H-2 - H-3, B: H-5 - H-7, C: H-9 - H-11, D: H<sub>2</sub>-13 - H<sub>2</sub>-14 and E: H<sub>3</sub>-16 - H-15 - H<sub>3</sub>-17, and these partial structures were connected by heteronuclear multiple-bond correlation spectroscopy (HMBC) (<xref ref-type="fig" rid="fig2">Figure 2</xref>). Partial structures A and B were connected through an oxygenated tertiary carbon at δ<sub>C</sub> 72.5 (C-4) by the following HMBC correlations: H<sub>3</sub>-18 to C-3, C-4 and C-5, partial structures B and C through an oxygenated tertiary carbon at δ<sub>C</sub> 72.9 (C-8) by the correlations: H<sub>3</sub>-19 to C-7, C-8 and C-9, and partial structures C and D through C-12 including the position of the carbonyl group by the following correlations: H-11 to C-20, H-13 (δ<sub>H</sub> 2.40) to C-20, H<sub>2</sub>-10 to C-12, and H<sub>2</sub>-14 to C-12. Finally, partial structures A and D were connected through the remaining oxygenated tertiary carbon at δ<sub>C</sub> 87.4 by the following correlations: H-2 to C-1 and H<sub>2</sub>-14 to C-1. The dimethyl group (partial structure E) was placed on C-1 by the HMBC correlations from H<sub>3</sub>-16 and H<sub>3</sub>-17 to C-1. Thus, a cyclic structure was proposed for sublylactone A (1), and the remaining one degree of unsaturation was expected to be compensated for by the formation of a lactone ring between the C-20 carboxylic acid and the hydroxy group at the C-1 position. Structurally related lactone cembranoids were isolated from Croton laevigatus as laevigatlac tones A-E and the relative structure of laevigatlactone A was determined by X-ray crystallographic analysis [<xref ref-type="bibr" rid="scirp.45238-ref8">8</xref>]. From the above evidence, the structure of sublylactone A (1) was expected to be that of a stereomeric isomer of laevigatlactone E (4), which was simultaneously isolated from this plant. On comparison of <sup>13</sup>C-NMR spectral data for sublylactone A (1) and laevigatlactone E (4) (<xref ref-type="table" rid="table2">Table 2</xref>), C-2 to C-7 showed some differences, C-2 by 2.1 ppm, C-4 by 1.6 ppm, C-6 by 0.7 and C-7 by 0.7 ppm. The most prominent difference was observed between the C-18 methyls, 6.2 ppm (<xref ref-type="table" rid="table2">Table 2</xref>). Therefore, the structure of sublylactone A (1) was elucidated to be 4-epi-lae- vigatlactone E, as shown in <xref ref-type="fig" rid="fig1">Figure 1</xref>.</p><p>Sublylactone B (2), [M]<sub>D</sub> ‒1.45, was isolated as an amorphous powder and its elemental composition was the same as that of 1, NMR spectroscopic data also indicating that 2 possessed the same functionality as that of 1. The geometry of two disubstituted double bonds (C-2=C-3 and C-6=C-7) was assigned as E from the coupling constants of their olefinic protons. The remaining double bond (C-11=C-12) was assigned to Z geometry from the significant evidence of the NOE correlation between the olefinic proton at H-11 (M<sub>H</sub> 5.91) and H<sub>2</sub>-13 (δ<sub>H</sub> 2.48) in the phase-sensitive NOESY spectrum (<xref ref-type="fig" rid="fig3">Figure 3</xref>). The relative structures of the methyl groups at the 4- and 8-positions were estimated to be in a β orientation from the NOE correlation peaks between H<sub>3</sub>-18 and H-7, H<sub>3</sub>-19 and H-7, and H<sub>3</sub>-19 and H-10 (δ<sub>H</sub> 3.47) (<xref ref-type="fig" rid="fig3">Figure 3</xref>). Therefore, the relative structure was elucidated to be as shown in <xref ref-type="fig" rid="fig1">Figure 1</xref>.</p><p>Phenolic compound (3), [α]<sub>D</sub><sup>25</sup> ‒0.47, was isolated as an amorphous powder and its elemental composition was determined to be C<sub>19</sub>H<sub>22</sub>O<sub>6</sub> by positive-ion HR-ESI-MS. The IR spectrum exhibited distinct absorptions assignable to hydroxy groups (3445 cm<sup>‒1</sup>) and an ester functional group (1701 cm<sup>‒1</sup>). The <sup>1</sup>H NMR together with the <sup>13</sup>C spectral data suggested the presence of monosubstituted and symmetrically tetrasubstituted aromatic rings as well as one methoxy signal (δ<sub>H</sub> 3.87) for six protons, and one methoxy signal (δ<sub>H</sub> 3.23) for three protons</p><fig id="fig1"  position="float"><label><xref ref-type="fig" rid="fig1">Figure 1</xref></label><caption><title> Structures of compounds isolated</title></caption><graphic mimetype="image"   position="float"  xlink:type="simple"  xlink:href="http://html.scirp.org/file/27-2601378x5.png"/></fig><fig id="fig2"  position="float"><label><xref ref-type="fig" rid="fig2">Figure 2</xref></label><caption><title> HMBC correlations of 1</title></caption><graphic mimetype="image"   position="float"  xlink:type="simple"  xlink:href="http://html.scirp.org/file/27-2601378x6.png"/></fig><table-wrap id="table1" ><label><xref ref-type="table" rid="table1">Table 1</xref></label><caption><title> <sup>1</sup>H-NMR spectral data for sublylactones A (1) and B (2), and 4 (CDCl<sub>3</sub>, 600 MHz)</title></caption><table><tbody><thead><tr><th align="center" valign="middle" >H</th><th align="center" valign="middle"  colspan="2"  >1</th><th align="center" valign="middle" >2</th><th align="center" valign="middle" >3</th></tr></thead><tr><td align="center" valign="middle" >2</td><td align="center" valign="middle" >5.41 (d, 16)</td><td align="center" valign="middle" >[5.48] (d, 16)</td><td align="center" valign="middle" >5.60 (d, 16)</td><td align="center" valign="middle" >[5.54] (d, 16)</td></tr><tr><td align="center" valign="middle" >3</td><td align="center" valign="middle" >5.45 (d, 16)</td><td align="center" valign="middle" >[5.36] (d, 16)</td><td align="center" valign="middle" >5.48 (d, 16)</td><td align="center" valign="middle" >[5.23] (d, 16)</td></tr><tr><td align="center" valign="middle" >5</td><td align="center" valign="middle" >2.34 (2H, d, 7)</td><td align="center" valign="middle" >[2.31] (2H, m)</td><td align="center" valign="middle" >2.09 (dd, 13, 12)</td><td align="center" valign="middle" >[2.18] (m)</td></tr><tr><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" >2.45 (ddd, 13,2,2)</td><td align="center" valign="middle" >[2.32] (ddd, 15, 3, 3)</td></tr><tr><td align="center" valign="middle" >6</td><td align="center" valign="middle" >5.45 (d, 16)</td><td align="center" valign="middle" >[5.38] (br d,16)</td><td align="center" valign="middle" >5.63 (ddd, 15, 12, 3)</td><td align="center" valign="middle" >[5.64] (ddd, 16, 11, 3)</td></tr><tr><td align="center" valign="middle" >7</td><td align="center" valign="middle" >5.49 (d, 16)</td><td align="center" valign="middle" >[5.41] (dd,16, 2)</td><td align="center" valign="middle" >5.35 (dd, 15, 2)</td><td align="center" valign="middle" >[5.34] (dd, 16,2)</td></tr><tr><td align="center" valign="middle" >9</td><td align="center" valign="middle" >1.87 (m)</td><td align="center" valign="middle" >[1.84] (2H, m)</td><td align="center" valign="middle" >1.66 (dd, 14, 14)</td><td align="center" valign="middle" >[1.85 (2H, m)</td></tr><tr><td align="center" valign="middle" ></td><td align="center" valign="middle" >1.90 (m)</td><td align="center" valign="middle" ></td><td align="center" valign="middle" >1.89 (m)</td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle" >10</td><td align="center" valign="middle" >2.16 (2H, m)</td><td align="center" valign="middle" >[2.18] (2H, m)</td><td align="center" valign="middle" >2.20 (m)</td><td align="center" valign="middle" >[2.15 (dd, 12, 3)</td></tr><tr><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" >3.47 (m)</td><td align="center" valign="middle" >[2.24] (m)</td></tr><tr><td align="center" valign="middle" >11</td><td align="center" valign="middle" >6.95 (m)</td><td align="center" valign="middle" >[6.89] (ddd, 11, 2, 2)</td><td align="center" valign="middle" >5.91 (ddd, 11, 2, 2)</td><td align="center" valign="middle" >[6.83] (ddd, 11, 2, 2)</td></tr><tr><td align="center" valign="middle" >13</td><td align="center" valign="middle" >2.35 (2H, dd, 14, 6)</td><td align="center" valign="middle" >[2.22] (m)</td><td align="center" valign="middle" >2.48 (2H, m)</td><td align="center" valign="middle" >[2.24] (m)</td></tr><tr><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" >[2.40] (ddd, 17, 2, 2)</td><td align="center" valign="middle" ></td><td align="center" valign="middle" >[2.44] (ddd, 17, 6, 5, 2)</td></tr><tr><td align="center" valign="middle" >14</td><td align="center" valign="middle" >1.79 (ddd, 14, 14, 6)</td><td align="center" valign="middle" >[1.76] (ddd, 14, 14, 6)</td><td align="center" valign="middle" >1.79 (m)</td><td align="center" valign="middle" >[1.75] (ddd, 14, 14, 6)</td></tr><tr><td align="center" valign="middle" ></td><td align="center" valign="middle" >1.95 (dd, 14, 6)</td><td align="center" valign="middle" >[2.04] (dd, 14, 6)</td><td align="center" valign="middle" >1.88 (m)</td><td align="center" valign="middle" >[2.01] (dd, 14, 6)</td></tr><tr><td align="center" valign="middle" >15</td><td align="center" valign="middle" >1.88 (m)</td><td align="center" valign="middle" >[1.86] (m)</td><td align="center" valign="middle" >1.84 (m)</td><td align="center" valign="middle" >[1.84] (m)</td></tr><tr><td align="center" valign="middle" >16</td><td align="center" valign="middle" >0.98 (3H, d, 7)</td><td align="center" valign="middle" >[0.98] (3H, d, 7)</td><td align="center" valign="middle" >0.95 (3H, d, 7)</td><td align="center" valign="middle" >[0.97] (3H, d, 7)</td></tr><tr><td align="center" valign="middle" >17</td><td align="center" valign="middle" >0.96 (3H, d, 7)</td><td align="center" valign="middle" >[0.99] (3H, d, 7)</td><td align="center" valign="middle" >0.96 (3H, d, 7)</td><td align="center" valign="middle" >[0.97] (3H, d, 7)</td></tr><tr><td align="center" valign="middle" >18</td><td align="center" valign="middle" >1.40 (3H, s)</td><td align="center" valign="middle" >[1.39] (3H, s)</td><td align="center" valign="middle" >1.39 (3H, s)</td><td align="center" valign="middle" >[1.28] (3H, s)</td></tr><tr><td align="center" valign="middle" >19</td><td align="center" valign="middle" >1.29 (3H, s)</td><td align="center" valign="middle" >[1.28] (3H, s)</td><td align="center" valign="middle" >1.21 (3H, s)</td><td align="center" valign="middle" >[1.31] (3H, s)</td></tr></tbody></table></table-wrap><p>Data in brackets are for CD<sub>3</sub>OD. In parentheses, number of hydrogen are specified, when they are not 1H. Letters and figures are multiplicities and J in Hz).</p><table-wrap id="table2" ><label><xref ref-type="table" rid="table2">Table 2</xref></label><caption><title> <sup>13</sup>C-NMR spectral data for sublylac- tones A (1) and B (2), and laevigatlactone E (4) (CDCl<sub>3</sub>, 150 MHz)</title></caption><table><tbody><thead><tr><th align="center" valign="middle" >C</th><th align="center" valign="middle" >1</th><th align="center" valign="middle" ></th><th align="center" valign="middle" >2</th><th align="center" valign="middle" >4</th><th align="center" valign="middle" ></th></tr></thead><tr><td align="center" valign="middle" >1</td><td align="center" valign="middle" >85.5</td><td align="center" valign="middle" >(87.4)</td><td align="center" valign="middle" >86.7</td><td align="center" valign="middle" >85.7</td><td align="center" valign="middle" >(87.7)</td></tr><tr><td align="center" valign="middle" >2</td><td align="center" valign="middle" >127.2</td><td align="center" valign="middle" >(128.4)</td><td align="center" valign="middle" >124.6</td><td align="center" valign="middle" >125.2</td><td align="center" valign="middle" >(126.3)</td></tr><tr><td align="center" valign="middle" >3</td><td align="center" valign="middle" >138.5</td><td align="center" valign="middle" >(140.0)</td><td align="center" valign="middle" >139.1</td><td align="center" valign="middle" >138.8</td><td align="center" valign="middle" >(140.3)</td></tr><tr><td align="center" valign="middle" >4</td><td align="center" valign="middle" >72.5</td><td align="center" valign="middle" >(73.0)</td><td align="center" valign="middle" >73.6</td><td align="center" valign="middle" >73.7</td><td align="center" valign="middle" >(74.1)</td></tr><tr><td align="center" valign="middle" >5</td><td align="center" valign="middle" >46.6</td><td align="center" valign="middle" >(48.4)</td><td align="center" valign="middle" >49.1</td><td align="center" valign="middle" >46.2</td><td align="center" valign="middle" >(47.6)</td></tr><tr><td align="center" valign="middle" >6</td><td align="center" valign="middle" >123.9</td><td align="center" valign="middle" >(125.0)</td><td align="center" valign="middle" >122.8</td><td align="center" valign="middle" >124.3</td><td align="center" valign="middle" >(125.7)</td></tr><tr><td align="center" valign="middle" >7</td><td align="center" valign="middle" >138.0</td><td align="center" valign="middle" >(139.1)</td><td align="center" valign="middle" >140.4</td><td align="center" valign="middle" >137.7</td><td align="center" valign="middle" >(138.4)</td></tr><tr><td align="center" valign="middle" >8</td><td align="center" valign="middle" >72.4</td><td align="center" valign="middle" >(72.9)</td><td align="center" valign="middle" >72.0</td><td align="center" valign="middle" >72.4</td><td align="center" valign="middle" >(73.0)</td></tr><tr><td align="center" valign="middle" >9</td><td align="center" valign="middle" >41.0</td><td align="center" valign="middle" >(42.4)</td><td align="center" valign="middle" >42.2</td><td align="center" valign="middle" >41.4</td><td align="center" valign="middle" >(42.5)</td></tr><tr><td align="center" valign="middle" >10</td><td align="center" valign="middle" >25.6</td><td align="center" valign="middle" >(25.9)</td><td align="center" valign="middle" >25.1</td><td align="center" valign="middle" >25.0</td><td align="center" valign="middle" >(25.9)</td></tr><tr><td align="center" valign="middle" >11</td><td align="center" valign="middle" >145.9</td><td align="center" valign="middle" >(148.5)</td><td align="center" valign="middle" >150.4</td><td align="center" valign="middle" >146.1</td><td align="center" valign="middle" >(148.4)</td></tr><tr><td align="center" valign="middle" >12</td><td align="center" valign="middle" >124.3</td><td align="center" valign="middle" >(125.5)</td><td align="center" valign="middle" >123.2</td><td align="center" valign="middle" >124.4</td><td align="center" valign="middle" >(125.6)</td></tr><tr><td align="center" valign="middle" >13</td><td align="center" valign="middle" >21.0</td><td align="center" valign="middle" >(21.9)</td><td align="center" valign="middle" >24.9</td><td align="center" valign="middle" >21.1</td><td align="center" valign="middle" >(22.0)</td></tr><tr><td align="center" valign="middle" >14</td><td align="center" valign="middle" >26.8</td><td align="center" valign="middle" >(28.2)</td><td align="center" valign="middle" >28.2</td><td align="center" valign="middle" >27.8</td><td align="center" valign="middle" >(28.9)</td></tr><tr><td align="center" valign="middle" >15</td><td align="center" valign="middle" >37.1</td><td align="center" valign="middle" >(38.3)</td><td align="center" valign="middle" >36.9</td><td align="center" valign="middle" >37.0</td><td align="center" valign="middle" >(38.1)</td></tr><tr><td align="center" valign="middle" >16</td><td align="center" valign="middle" >17.2</td><td align="center" valign="middle" >(17.7)</td><td align="center" valign="middle" >17.3</td><td align="center" valign="middle" >17.4</td><td align="center" valign="middle" >(17.7)</td></tr><tr><td align="center" valign="middle" >17</td><td align="center" valign="middle" >16.8</td><td align="center" valign="middle" >(16.9)</td><td align="center" valign="middle" >16.6</td><td align="center" valign="middle" >16.5</td><td align="center" valign="middle" >(16.8)</td></tr><tr><td align="center" valign="middle" >18</td><td align="center" valign="middle" >25.1</td><td align="center" valign="middle" >(24.7)</td><td align="center" valign="middle" >28.3</td><td align="center" valign="middle" >31.1</td><td align="center" valign="middle" >(30.9)</td></tr><tr><td align="center" valign="middle" >19</td><td align="center" valign="middle" >26.5</td><td align="center" valign="middle" >(25.8)</td><td align="center" valign="middle" >31.4</td><td align="center" valign="middle" >24.7</td><td align="center" valign="middle" >(24.7)</td></tr><tr><td align="center" valign="middle" >20</td><td align="center" valign="middle" >167.7</td><td align="center" valign="middle" >(170.6)</td><td align="center" valign="middle" >167.4</td><td align="center" valign="middle" >169.0</td><td align="center" valign="middle" >(170.7)</td></tr></tbody></table></table-wrap><p>Data in parentheses are for CD<sub>3</sub>OD.</p><fig id="fig3"  position="float"><label><xref ref-type="fig" rid="fig3">Figure 3</xref></label><caption><title> NOESY correlations of 1</title></caption><graphic mimetype="image"   position="float"  xlink:type="simple"  xlink:href="http://html.scirp.org/file/27-2601378x7.png"/></fig><p>(<xref ref-type="table" rid="table3">Table 3</xref>). From their chemical shifts, the former were expected to be on the aromatic carbons and the latter on the aliphatic carbon. The remaining signals comprised those of one methylene, one oxygenated methylene, one oxygenated methine and a carbonyl carbon. In the <sup>1</sup>H-<sup>1</sup>H COSY spectrum, two proton chains were observed, these are oxymethylene (H<sub>2</sub>-9)-methylene (H<sub>2</sub>-8)-oxymethine (H-7) and H-2' through H-4'. In the HMBC spectrum, oxymethylene protons (δ<sub>H</sub> 4.36 and 4.41) showed significant correlation cross peaks with the carbonyl carbon (δ<sub>C</sub> 166.5), to which the aromatic protons of H-2' and 6' [δ<sub>H</sub> 8.02 (2H, dd, J = 8, 1 Hz)] were also correlated. The oxymethylene protons further correlated with C-7 (δ<sub>C</sub> 81.2) and methylene protons (δ<sub>H</sub> 2.08 and 2.25) with C-1 (δ<sub>C</sub> 132.9). The positions of the methoxy groups were assigned as on C-3 and 5, and C-7 by the HMBC correlation shown in <xref ref-type="fig" rid="fig4">Figure 4</xref>. Therefore, the structure of 3 was elucidated to be 7-methoxydihydrosynapyl alcohol 9-O-benzoyl ester, as shown in <xref ref-type="fig" rid="fig1">Figure 1</xref>. Due to the very small optical rotation value, it is uncertain whether 3 is a racemic, partially racemic or chiral compound. A related compound, (7S)-7-methoxydihydro- synapyl alcohol (5) was isolated from Acer truncatum [<xref ref-type="bibr" rid="scirp.45238-ref9">9</xref>]. The optical rotation value of 5 was reported to be ‒6.8 in CHCl<sub>3</sub> ([M]<sub>D</sub> ‒16.4, where molecular rotation is calculated as [M]<sub>D</sub>=[α]<sub>D</sub><sub> </sub>&#215; MW./100). Thus, 3 ([M]<sub>D</sub> ‒5.0) was estimated to be nearly a racemic compound in which an S-form is slightly dominant.</p></sec><sec id="s3"><title>3. Material and Method</title><sec id="s3_1"><title>3.1. Plant Material</title><p>Leaves of C. sublyratus were collected in the Botanical Garden of the Faculty of Pharmacy, Chiang Mai University, Thailand in July 2008. A voucher specimen was deposited in the Herbarium of the Faculty of Pharmacy, Chiang Mai University（CS-CMU-July-2008).</p></sec><sec id="s3_2"><title>3.2. General Experimental Proceddures</title><p>Optical rotations were measured on a JASCO P-1030 digital polarimeter. IR and UV spectra were measured on Horiba FT-710 and JASCO V-520 UV/Vis spectrophotometers, respectively. <sup>1</sup>H- and <sup>13</sup>C-NMR spectra were taken on a JEOL ECA-600 at 600 MHz and 150 MHz with tetramethylsilane as an internal standard. Positive- ion HR-ESI-MS was performed with an Applied Biosystems QSTAR XL NanoSprayTM System. Silica gel CC was performed on silica gel 60 (E. Merck, Darmstadt, Germany).</p><table-wrap id="table3" ><label><xref ref-type="table" rid="table3">Table 3</xref></label><caption><title> NMR spectroscopic data for compound 1 (3) (CDCl<sub>3</sub>, <sup>13</sup>C: 100 MHz, <sup>1</sup>H: 400 MHz)</title></caption><table><tbody><thead><tr><th align="center" valign="middle" ></th><th align="center" valign="middle" >C</th><th align="center" valign="middle" >H</th></tr></thead><tr><td align="center" valign="middle" >1</td><td align="center" valign="middle" >132.9</td><td align="center" valign="middle" >-</td></tr><tr><td align="center" valign="middle" >2, 6</td><td align="center" valign="middle" >103.3</td><td align="center" valign="middle" >6.55 (2H, s)</td></tr><tr><td align="center" valign="middle" >3, 5</td><td align="center" valign="middle" >147.3</td><td align="center" valign="middle" >-</td></tr><tr><td align="center" valign="middle" >4</td><td align="center" valign="middle" >134.3</td><td align="center" valign="middle" >-</td></tr><tr><td align="center" valign="middle" >7</td><td align="center" valign="middle" >81.2</td><td align="center" valign="middle" >4.22 (1H, dd, 8, 6)</td></tr><tr><td align="center" valign="middle" >8</td><td align="center" valign="middle" >37.4</td><td align="center" valign="middle" >2.08 (1H, m)</td></tr><tr><td align="center" valign="middle" ></td><td align="center" valign="middle"  colspan="2"  >2.25 (1H, m)</td></tr><tr><td align="center" valign="middle" >9</td><td align="center" valign="middle" >62.4</td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle" ></td><td align="center" valign="middle"  colspan="2"  >4.41 (1H, m)</td></tr><tr><td align="center" valign="middle" >1’</td><td align="center" valign="middle" >130.4</td><td align="center" valign="middle" >-</td></tr><tr><td align="center" valign="middle" >2’, 6’</td><td align="center" valign="middle" >129.5</td><td align="center" valign="middle" >8.02 (2H, dd, 8, 1)</td></tr><tr><td align="center" valign="middle" >3’, 5’</td><td align="center" valign="middle" >128.4</td><td align="center" valign="middle" >7.44 (2H, dd, 8, 8)</td></tr><tr><td align="center" valign="middle" >4’</td><td align="center" valign="middle" >132.9</td><td align="center" valign="middle" >7.56 (1H, tt, 8, 1)</td></tr><tr><td align="center" valign="middle" >7’</td><td align="center" valign="middle" >166.5</td><td align="center" valign="middle" >-</td></tr><tr><td align="center" valign="middle" >4’-OH</td><td align="center" valign="middle" ></td><td align="center" valign="middle" >5.49 (1H, s)</td></tr><tr><td align="center" valign="middle" >3, 5-OMe</td><td align="center" valign="middle" >56.4</td><td align="center" valign="middle" >3.87 (6H, s)</td></tr><tr><td align="center" valign="middle" >7Me</td><td align="center" valign="middle" >56.6</td><td align="center" valign="middle" >3.23 (3H, s)</td></tr></tbody></table></table-wrap><fig id="fig4"  position="float"><label><xref ref-type="fig" rid="fig4">Figure 4</xref></label><caption><title> HMBC correlations of compound 1 (3)</title></caption><graphic mimetype="image"   position="float"  xlink:type="simple"  xlink:href="http://html.scirp.org/file/27-2601378x8.png"/></fig></sec><sec id="s3_3"><title>3.3. Extraction and Isolation</title><p>Powdered and air-dried leaves of C. sublyratus (450 g) were extracted with MeOH (2 L &#215; 3) and the total extracts were concentrated to 1 L. The concentrated MeOH extract was washed with n-hexane (1 L, 7.35 g) and then the remaining MeOH layer was concentrated to a viscous gum. The viscous gum was suspended in H<sub>2</sub>O (1 L), and then partitioned successively with EtOAc (1 L) and 1-BuOH (1 L) to give EtOAc-soluble (24.0 g) and 1-BuOH-soluble (7.88 g) fractions, respectively. The H<sub>2</sub>O layer was evaporated to leave 16.3 g of a residue.</p><p>The residue (24.0 g) of the EtOAc-soluble fraction was subjected to silica gel (500 g) CC with a solvent system consisting of n-hexane (3 L), n-hexane-EtOAc [9:1 (3 L), 4:1 (3 L), 7:3 (3 L), 3:2 (3 L), 1:1 (3 L), and 3:7 (3 L)], EtOAc (3 L), and MeOH (3 L), 1 L fractions being collected. The residue (3.51 g) in fractions 6 - 8 was fractionated by ODS CC (Cosmosil 75 C<sub>18</sub>OPN) (Φ = 40 mm, L = 250 mm), by elution with H<sub>2</sub>O-MeOH [(3:7, 800 mL), (1:3, 800 mL), (1:4, 800 mL), (3:17, 800 mL), (1:9, 800 mL), and (1:19, 800 mL)], MeOH (800 mL), (CH<sub>3</sub>)<sub>2</sub>CO (800 mL), and EtOAc (800 mL), 800 mL fractions being collected. The residue (745 mg) in fraction 1 was further separated by ODS CC (Cosmosil 75 C<sub>18</sub>OPN) (Φ = 40 mm, L = 250 mm) using H<sub>2</sub>O-MeOH [(7:3, 800 mL), (3:2, 800 mL), (1:1, 800 mL), (2:3, 800 mL), (7:13, 800 mL), and (3:7. 800 mL)], and MeOH (800 mL), 800 mL-fractions being collected. The residue (108 mg) in fraction 4 was again purified by silica gel CC (Φ = 10 mm, L = 30 cm) with a linear gradient solvent system from n-hexane (250 mL) to n-hexane-EtOAc (1:1, 250 mL), 4-gram fractions being collected. From fractions 109‒120, 5.6 mg of 2 was obtained.</p><p>The residue (869 mg) in fractions 11 - 12 obtained on the first silica gel CC was separated by ODS CC with H<sub>2</sub>O-MeOH [(7:3, 800 mL), (3:2, 800 mL), (1:1, 800 mL), (2:3, 800 mL), (7:13, 800 mL), (3:7. 800 mL), (1:3, 800 mL), (1:4, 800 mL), (3:17, 800 mL), (1:9, 800 mL), and (1:19, 800 mL)], MeOH (800 mL), (CH<sub>3</sub>)<sub>2</sub>CO (800 mL), and EtOAc (800 mL), 800 mL fractions being collected. The residue (203 mg) in fraction 3 was purified by silica gel CC (Φ = 10 mm, L = 40 cm) with a linear gradient solvent system from n-hexane (250 mL) to n-hexane-EtOAc (1:1, 250 mL), 4-gram fractions being collected. Further amounts of n-hexane-EtOAc (1:1, 750 mL) and MeOH (250 mL) were eluted and 250 mL-fractions were collected. From the third n-hexane-EtOAc (1:1, 250 mL) fraction, 11.0 mg of 4 was obtained. The residue (276 mg) in fraction 4 was separated by silica gel CC (Φ = 10 mm, L = 40 cm) with a linear gradient solvent system from n-hexane (250 mL) to n-hexane- EtOAc (1:1, 250 mL), 4-gram fractions being collected. From fractions 67 - 74, 20.0 mg of 3 was obtained.</p><p>The residue (1.17 g) in fractions 13 - 14 obtained on the first silica gel CC was separated by ODS CC with H<sub>2</sub>O-MeOH [(7:3, 800 mL), (3:2, 800 mL), (1:1, 800 mL), (2:3, 800 mL), (7:13, 800 mL), (3:7. 800 mL), (1:3, 800 mL), (1:4, 800 mL), (3:17, 800 mL), (1:9, 800 mL), and (1:19, 800 mL)], MeOH (800 mL), (CH<sub>3</sub>)<sub>2</sub>CO (800 mL), and EtOAc (800 mL), 800 mL fractions being collected. The residue (121 mg) in fraction 3 was purified by silica gel CC (Φ = 10 mm, L = 34 cm) with a linear gradient solvent system from n-hexane (250 mL) to n-hexane-EtOAc (1:1, 250 mL), and n-hexane-EtOAc (1:1, 700 mL). Further amounts of n-hexane-EtOAc (1:1, 250 mL) and MeOH (250 mL) were eluted. From the final 250 mL n-hexane-EtOAc fraction, 8.2 mg of 1 was obtained.</p><p>The residue (779 mg) in fractions 17 - 18 obtained on the first silica gel CC was separated by ODS CC with H<sub>2</sub>O-MeOH [(7:3, 800 mL), (3:2, 800 mL), (1:1, 800 mL), (2:3, 800 mL), (7:13, 800 mL), (3:7. 800 mL), (1:3, 800 mL), (1:4, 800 mL), (3:17, 800 mL), (1:9, 800 mL), and (1:19, 800 mL)], MeOH (800 mL), (CH<sub>3</sub>)<sub>2</sub>CO (800 mL), and EtOAc (800 mL), 800 mL fractions being collected. The residue (74.2 mg) in fraction 3 was purified by silica gel CC (Φ = 10 mm, L = 28 cm) with a linear gradient solvent system from n-hexane (250 mL) to n-hexane-EtOAc (1:1, 250 mL), 4-gram fractions being collected. From fractions 101 - 124, a further amount of 2 (17.2 mg) was obtained.</p></sec><sec id="s3_4"><title>3.4. Sublylactone A (1)</title><p>Amorphous powder, [α]<sub>D</sub><sup>23</sup> +3.90 (c 0.28, CHCl<sub>3</sub>); IR ν<sub>max</sub> (film) cm<sup>‒1</sup>: 3423, 2968, 2929, 2881, 1697, 1631, 1469, 1371, 1320, 1267, 1094, 977; UV λ<sub>max</sub> (MeOH) nm (log ε): 234 (3.56); <sup>1</sup>H-NMR (CDCl<sub>3 </sub>and CD<sub>3</sub>OD, 600 MHz): <xref ref-type="table" rid="table1">Table 1</xref>; <sup>13</sup>C-NMR (CDCl<sub>3 </sub>and CD<sub>3</sub>OD, 150 MHz): <xref ref-type="table" rid="table2">Table 2</xref>; HR-ESI-MS (positive-ion mode): 357.2036 [M + Na]<sup>+</sup> (Calcd for C<sub>20</sub>H<sub>30</sub>O<sub>4</sub>Na: 357.2036).</p></sec><sec id="s3_5"><title>3.5. Sublylactone B (2)</title><p>Amorphous powder, [α]<sub>D</sub><sup>25</sup> ‒1.45 (c 0.46, CD<sub>3</sub>OD); IR ν<sub>max</sub> (film) cm<sup>‒1</sup>: 3445, 2967, 2929, 2881, 1693, 1630, 1455, 1381, 1320, 1244, 1118, 978; UV λ<sub>max</sub> (MeOH) nm (log ε): 233 (3.76); <sup>1</sup>H-NMR (CDCl<sub>3</sub>, 600 MHz): <xref ref-type="table" rid="table1">Table 1</xref>; <sup>13</sup>C-NMR (CDCl<sub>3</sub>, 150 MHz): <xref ref-type="table" rid="table1">Table 1</xref>; HR-ESI-MS (positive-ion mode): 357.2031 [M + Na]<sup>+</sup> (Calcd for C<sub>20</sub>H<sub>30</sub>O<sub>4</sub>Na: 357.2036).</p></sec><sec id="s3_6"><title>3.6. Compound 1 (3)</title><p>Amorphous powder, [α]<sub>D</sub><sup>25</sup> ‒0.47 (c 0.54, CHCl<sub>3</sub>); IR ν<sub>max</sub> (film) cm<sup>‒1</sup>: 3445, 2962, 2934, 2841, 1701, 1274; UV λ<sub>max</sub> (MeOH) nm (log ε): 212 (4.20), 227 (4.14); <sup>1</sup>H-NMR (CDCl<sub>3</sub>, 600 MHz): <xref ref-type="table" rid="table3">Table 3</xref>; <sup>13</sup>C-NMR (CDCl<sub>3</sub>, 150 MHz): <xref ref-type="table" rid="table3">Table 3</xref>; HR-ESI-MS (positive-ion mode): 369.1311 [M + Na]<sup>+</sup> (Calcd for C<sub>19</sub>H<sub>22</sub>O<sub>6</sub>Na: 369.1308).</p></sec></sec><sec id="s4"><title>Acknowledgements</title><p>The authors are grateful for access to the superconducting NMR instrument (JEOL JNM α-400) and an Applied Biosystem QSTAR XL system ESI (Nano Spray)-MS at the Analysis Center of Life Science of the Graduate School of Biomedical Sciences, Hiroshima University. This work was supported in part by Grants-in-Aid from the Ministry of Education, Culture, Sports, Science and Technology of Japan, and the Japan Society for the Promotion of Science. Thanks are also due to the Research Foundation for Pharmaceutical Sciences and the Takeda Science Foundation for the financial support.</p></sec></body><back><ref-list><title>References</title><ref id="scirp.45238-ref1"><label>1</label><mixed-citation publication-type="other" xlink:type="simple">Kapchan, S.M., Komoda, Y., Court, W.A., Thomas, G.J., Smith, R.M., Karim, A., Gilmore, C.J., Haltiwagner, R.C. and Bryan, B.F. (1972) Maytansine, a Novel Antileukemic Ansa Macrolide from Maytenus ovate. Journal of American Chemical Society, 94, 1354-1956. http://dx.doi.org/10.1021/ja00759a054</mixed-citation></ref><ref id="scirp.45238-ref2"><label>2</label><mixed-citation publication-type="other" xlink:type="simple">Cassady, J.M., Chan, K.K., Floss, H.G. and Leistner, E. (2004) Recent Developments in the Maytansinoid Antitumor Agents. Chemical and Pharmaceutical Bulletin, 52, 1-26. http://dx.doi.org/10.1248/cpb.52.1</mixed-citation></ref><ref id="scirp.45238-ref3"><label>3</label><mixed-citation publication-type="other" xlink:type="simple">Koyama, Y., Sugimoto, S., Matsunami, K. and Otsuka, H. (2010) Microtropiosides A-F: ent-Labdane Diterpenoid Glucosides from the Leaves of Microtropis japonica (Celastraceae). Phytochemistry, 71, 67-681. http://dx.doi.org/10.1016/j.phytochem.2010.01.004</mixed-citation></ref><ref id="scirp.45238-ref4"><label>4</label><mixed-citation publication-type="other" xlink:type="simple">Uemura, Y., Sugimoto, S., Matsunami, K., Otsuka, H., Takeda, Y., Kawahata, M. and Yamaguchi, K. (2013) Microtropins A-I: 6'-O-(2"S,3"R)-2"-Ethyl-2",3"-Dihydroxybutyrates of Aliphatic Alcohol β-D-Glucopyranosides from the Branches of Microtropis japonica. Phytochemistry, 87, 140-147. http://dx.doi.org/10.1016/j.phytochem.2012.11.007</mixed-citation></ref><ref id="scirp.45238-ref5"><label>5</label><mixed-citation publication-type="other" xlink:type="simple">Sakushima, A., Coskun, M. and Maoka, T. (1995) Hydroxy-Benzoic Acids from Boreava orientalis. Phytochemistry, 40, 257-261. http://dx.doi.org/10.1016/0031-9422(95)00059-G</mixed-citation></ref><ref id="scirp.45238-ref6"><label>6</label><mixed-citation publication-type="other" xlink:type="simple">Asakawa, Y., Toyota, M. and Harrison, L. (1985) Isotachin A and Isotachin B, Two Sulphur-Containing Acrylates from the Liverwort Isotachis japonica. Phytochemistry, 24, 1505-1508. http://dx.doi.org/10.1016/S0031-9422(00)81055-9</mixed-citation></ref><ref id="scirp.45238-ref7"><label>7</label><mixed-citation publication-type="other" xlink:type="simple">Balboul, B.A.A.A., Ahmed, A.A., Otsuka, H. and de Adams, A. (1996) 4-Hydroxyphenylpropan-7,8-Diols and Derivatives from Narvalina domingensis. Phytochemisty, 42, 1191-193. http://dx.doi.org/10.1016/0031-9422(96)00116-1</mixed-citation></ref></ref-list></back></article>